In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer ...

Given the highly infectious nature of the COVID pathogen, tests for the virus had to be quick, reliable and safe. The test ...

Happiest Diagnostics, under Happiest Health, has secured NABL accreditation within two years of its inception, paving the way for growth in molecular, genomic, and preventive diagnostics. This ...

Congenital stationary night blindness (CSNB) is caused by mutations in a specific calcium channel. A comprehensive proteomic study by researchers at the University of Innsbruck now reveals how these ...

A pilot study has found evidence of Bartonella and Babesia infection in almost half of 50 blood samples from patients ...

In a move aimed at revising and standardising laboratory testing charges for drugs, vaccines, and traditional medicines, the ...

Shrinking transistors has driven computing performance for decades, but the approach is hitting physical ...

Quest expects the new blood test will support response monitoring in clinical trials.

A research team led by La Trobe University has developed a single-use test strip which could ultimately change how diseases like cancer are diagnosed. The research, published in the journal Small, ...